Is It Time to Put a Moratorium on New Infant Formulas that Are Not Adequately Investigated? - 25/02/15
Doi : 10.1016/j.jpeds.2014.11.003
Steven A. Abrams, MD ⁎ 
Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX
∗Reprint requests: Steven A. Abrams, MD, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, 1100 Bates St, Houston, TX 77030.
Keyword : AAP, FDA, IFA, IOM, USDA, WHO, WIC
Le texte complet de cet article est disponible en PDF.
Plan
| S.A. is the principal investigator of an investigator-initiated study related to postdischarge management of preterm infants funded by Mead Johnson Nutrition (Evansville, Indiana). |
© 2015
Elsevier Inc. Tous droits réservés.
Vol 166 - N° 3
P. 756-760 - mars 2015 Retour au numéro
Article précédent
- Fever Is Common Postoperatively Following Posterior Spinal Fusion: Infection Is an Uncommon Cause
- Gideon W. Blumstein, Lindsay M. Andras, Derek A. Seehausen, Liam Harris, Patrick A. Ross, David L. Skaggs
- Serum Anti-Tissue Transglutaminase Antibodies Detected during Febrile Illness May Not Be Produced by the Intestinal Mucosa
- Luigina De Leo, Sara Quaglia, Fabiana Ziberna, Serena Vatta, Stefano Martelossi, Massimo Maschio, Tarcisio Not
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?